~~<i id='01FF71D8A5'><strike id='01FF71D8A5'><tt id='01FF71D8A5'><pre id='01FF71D8A5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：hotspot 2025-09-27 22:46:10 - browse：95525

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： UnitedHealth argues against case alleging wrongful AI care denials

explore

focus

explore

leisure time

explore

Wikipedia

Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

WSS

UnitedHealth argues against case alleging wrongful AI care denials

Scrutiny of post

Digital health: a case of mistaken identity

H5N1 bird flu outbreak: Second human case reported, in Michigan

Adam's Take: Intra

'Patient friction coefficient' can gauge a clinical trial's patient burden

hotspot

entertainment

explore

As demand for Covid shots wanes, Moderna seeks its next success

6 surprising facts about sugar

In age of alternative facts, a scholarly course on calling out crap

CRISPR technology availability, affordability needs to be expanded

Hepatitis C has a cure — but many Americans still lack access to it

This gene therapy has record $4.25 million price. It's saved children.

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Trump demands the U.S. pay no more for drugs than other countries … again

Liver decline slowed by off

focus

Questions and answers about ramping up H5N1 bird flu vaccine

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Addressing health care workers' trauma can help fight burnout

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Digital health: a case of mistaken identity

Yancopoulos of Regeneron works to expand Dupixent success

explore

leisure time

explore

Wikipedia